A survey of vitiligo management among dermatologists in Saudi Arabia

Journal of the European Academy of Dermatology and Venereology

Volumn 23, Issue 11, 2009, Pages 1282-1288

  Alghamdi, Km ^a  

^a KING SAUD UNIVERSITY   (Saudi Arabia)

Author keywords

Dermatologist; Phototherapy; Saudi Arabia; Therapy; Vitiligo

Indexed keywords

PIMECROLIMUS; PSORALEN; STEROID; TACROLIMUS;

ARTICLE; HUMAN; PHOTOTHERAPY; PRIORITY JOURNAL; PUVA; SAUDI ARABIA; SKIN PIGMENTATION; ULTRAVIOLET B RADIATION; VITILIGO;

ADRENAL CORTEX HORMONES; DERMATOLOGY; HUMANS; PATIENT ACCEPTANCE OF HEALTH CARE; PHYSICIAN'S PRACTICE PATTERNS; PUVA THERAPY; QUESTIONNAIRES; SAUDI ARABIA; VITILIGO;

EID: 70349954963     PISSN: 09269959     EISSN: 14683083     Source Type: Journal    
DOI: 10.1111/j.1468-3083.2009.03310.x     Document Type: Article

References (33)

1. Mahmoud BH, Hexsel CL, Hamzavi IH. An update on new and emerging options for the treatment of vitiligo. Skin Ther Lett 2008 13 : 1 6.
2. Kostovic K, Pasic A. New treatment modalities for vitiligo focus on topical immunomodulators. Drugs 2005 65 : 447 459.
3. Mosher DB, Fitzpatrick TB, Ortonne JP. Disorder of pigmentation: vitiligo. In : Fitzpatrick TB, Eisen AZ, Wolff K et al. Dermatology in General Medicine, 1st edn. McGraw-Hill, New York, 1993 : 903 995.
4. Pianigiani E, Andreassi A, Andreassi L. Autografts and cultured epidermis in the treatment of vitiligo. Clinics Dermatol 2005 23 : 424 429.
5. Woolf SH. Practice guidelines: a new reality in medicine. II. Methods of developing guidelines. Arch Intern Med 1992 152 : 946 952.
6. Ladhani S. The need for evidence based management of skin diseases. Int J Dermatol 1997 36 : 17 22.
7. Njoo MD, Bossuyt PMM, Westerhof W. Management of vitiligo. Results of a questionnaire among dermatologists in the Netherlands. Int J Dermatol 1999 38 : 866 872.
8. Ongenae K, Van Gell N, De Schepper S et al. Management of vitiligo patients and attitude of dermatologists towards vitiligo. Eur J Dermatol 2004 14 : 177 181.
9. Drake LA, Dinehart SM, Farmer ER et al. Guidelines of care for vitiligo. American Academy of Dermatology. J Am Acad Dermatol 1996 35 : 620 626.
10. Westerhof W, Bolhaar B, Menke HE, Harper JI. Resultaten van een enqueete onder vitiligo patienten. Ned Tijdschr Dermatol Venereol 1996 6 : 100 105.
11. Hann SK, Chun WH, Park YK. Clinical characteristics of progressive vitiligo. Int J Dermatol 1997 36 : 353 355.
12. Chun WH, Hann SK. The progression of non-segmental vitiligo: clinical analysis of 318 patients. Int J Dermatol 1997 36 : 908 910.
13. Berneburg M, Rocken M, Benedic F. Phototherapy with narrowband vs. broadband UVB. Acta Derm Venereol 2005 85 : 98 108.
14. Lepe V, Moncada B, Castanedo- Cazares JP, Torres-Alvarez MB, Ortiz CA, Torres-Rubalcava ABA. Double-blind randomized trial of 0. 1% tacrolimus vs 0.05% clobetasol for the treatment of childhood vitiligo. Arch Dermatol 2003 139 : 581 585.
15. Crimes PE, Morris R, Avaniss-Aghajani E, Soriano T, Meraz M, Metzger A. Topical tacrolimus therapy for vitiligo: therapeutic responses and skin messenger RNA expression of proinflammatory cytokines. J Am Acad Dermatol 2004 51 : 52 61.
16. Al-Qattan MM. Pediatric burns induced by psoralens in Saudi Arabia. Burns 2000 26 : 653 655.
17. Valkova S, Trashlieva M, Christova P. Treatment of vitiligo with local khellin and UVA: comparison with systemic PUVA. Clin Exp Dermatol 2004 29 : 180 184.
18. Grimes PE. New insights and new therapies in vitiligo. JAMA 2005 293 : 730 735.
19. Parsad D, Kanwar AJ, Kumar B, Psoralen-ultraviolet A. vs. Narrow-band ultraviolet B phototherapy for the treatment of vitiligo. J Eur Acad Dermatol Venerol 2006 20 : 175 177.
20. Yones SS, Palmer RA, Garibaldinos TM et al. Randomized double-blind trial of treatment of vitiligo: efficacy of psoralen-UVA therapy vs. Narrowband - UVB Therapy. Arch Dermatol 2007 143 : 578 584.
21. Esposito M, Soda R, Costanzo A, Chimenti S. Treatment of vitiligo with the 308 nm excimer laser. Clin Exp Dermatol 2004 29 : 133 137.
22. Ostavari N, Passeron T, Zakaria W et al. Treatment of vitiligo by 308-nm excimer laser: an evaluation of variables affecting treatment response. Laser Surg Med 2004 35 : 152 156. (Pubitemid 39150415)
23. Hadi S, Tinio P, Al Ghaithi K et al. Treatment of vitiligo using the 308 nm excimer laser. Photomed Laser Surg 2006 24 : 354 357.
24. Sitek JC, Loeb M, Ronnevig JR. Narrowband UVB therapy for vitiligo: does the repigmentation last?. J Eur Acad Dermatol Venereol 2007 21 : 891 896.
25. Stern R, Lunder EJ. Risk of squamous cell carcinoma and methoxsalen (psoralen) and UV-A radiation (PUVA) A meta-analysis. Arch Dermatol 1998 134 : 1582 1585.
26. Park HS, Lee YS, Chun DK. Squamous cell carcinoma in vitiligo lesion after long-term PUVA therapy. J Eur Acad Dermatol Venereol 2003 17 : 578 580.
27. Takeda H, Mitsuhashi Y, Kondo S. Multiple squamous cell carcinomas in situ in vitiligo lesions after long-term PUVA therapy. J Am Acad Dermatol 1998 38 (2 Part 1 268 270.
28. Buckley DA, Rogers S. Multiple keratoses and squamous carcinoma after PUVA treatment of vitiligo. Clin Exp Dermatol 1996 21 : 43 45.
29. Schallreuter KU, Tobin DJ, Panske A. Decreased photodamage and low incidence of non-melanoma skin cancer in 136 sun-exposed Caucasian patients with vitiligo. Dermatology 2002 204 : 194 201.
30. Pathak MA, Moshar DB, Fitzpatrick TB. Safety and therapeutic effectiveness of 8-methoxypsoralen, 4,5,8- trimethylpsoralen, and psoralen in vitiligo. Natl Cancer Inst Monogr 1984, 66 : 165 173.
31. Koster W, Wiskemann A. Phototherapy with UV-B in vitiligo. Zeitschr Hautkrank 1990 65 : 1022 1024.
32. Westerhof W, Neiuweboer Krobotova I. Treatment of vitiligo with narrowband UV-B versus topical psoralen plus UVA. Arch Dermatol 1997 133 : 1525 1528.
33. Bose SK. Absence of Merkel cells in Lesional skin of vitiligo (corrected). Published erratum appears in International J Dermatol 1995 Jan; 34 (1): 66. Inter J Dermatol 1994 33 : 481 483.